Eton Pharmaceuticals (ETON) Revenue Growth (3y) (2022 - 2025)
Eton Pharmaceuticals (ETON) Revenue Growth (3y) (2022 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.69 Bn | 87.82 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.96 Bn | 32.22 Bn | 1.97 Bn | 2.84% |
| 3 | Zoetis | 32.61 Bn | 30.67 Bn | 1.62 Bn | 4.19% |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn | -4.46% |
| 5 | United Therapeutics | 23.06 Bn | 20.91 Bn | 648.10 Mn | 15.52% |
| 6 | RedHill Biopharma | 22.43 Bn | 22.43 Bn | - | - |
| 7 | Viatris | 20.25 Bn | 18.44 Bn | 1.16 Bn | -2.00% |
| 8 | Neurocrine Biosciences | 17.75 Bn | 16.43 Bn | 800.70 Mn | 24.66% |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 2.94% |
| 10 | Eton Pharmaceuticals | 1.14 Bn | 1.12 Bn | 13.10 Mn | 35.80% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 35.80% |
| Sep 30, 2025 | 65.00% |
| Jun 30, 2025 | 55.85% |
| Mar 31, 2025 | 99.52% |
| Dec 31, 2024 | 24.11% |
| Sep 30, 2024 | 137.05% |
| Jun 30, 2024 | 43.56% |
| Mar 31, 2024 | -12.51% |
| Dec 31, 2023 | 2,049.83% |
| Sep 30, 2023 | 252.10% |
| Jun 30, 2023 | 743.36% |
| Mar 31, 2023 | 276.98% |
| Dec 31, 2022 | 164.55% |
| Mar 31, 2022 | 63.27% |